Cargando…

The need for evidence‐based treatment decisions in spinal muscular atrophy type 0

Detalles Bibliográficos
Autores principales:	Erbas, Yasemin, Gusset, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528450/ https://www.ncbi.nlm.nih.gov/pubmed/34546649 http://dx.doi.org/10.1002/acn3.51459

Ejemplares similares

Reply to: The need for evidence‐based treatment decisions in spinal muscular atrophy type 0
por: Mercuri, Eugenio, et al.
Publicado: (2021)

Very severe spinal muscular atrophy (Type 0)
por: Al Dakhoul, Suleiman
Publicado: (2017)

The Burden of Primary Caregivers of Spinal Muscular Atrophy Patients and Their Needs
por: Evkaya Acar, Ayça, et al.
Publicado: (2021)

Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures
por: Aponte Ribero, Valerie, et al.
Publicado: (2023)

Nusinersen in type 0 spinal muscular atrophy: should we treat?
por: Tiberi, Eloisa, et al.
Publicado: (2020)

Very severe spinal muscular atrophy: Type 0 with Dandy-Walker variant
por: Gathwala, Geeta, et al.
Publicado: (2014)

It’s time to measure disability in spinal muscular atrophy
por: Trabacca, Antonio, et al.
Publicado: (2022)

Do we always need to treat patients with spinal muscular atrophy? A personal view and experience
por: Agosto, Caterina, et al.
Publicado: (2021)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Type 0 Spinal Muscular Atrophy in rare association with congenital Contracture and generalized osteopenia
por: SINGH, Aditi, et al.
Publicado: (2018)

Antisense-based therapy for the treatment of spinal muscular atrophy
por: Rigo, Frank, et al.
Publicado: (2012)

Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy
por: Lusakowska, Anna, et al.
Publicado: (2021)

A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland
por: Gillingwater, Thomas H., et al.
Publicado: (2022)

Nusinersen Treatment in Adults With Spinal Muscular Atrophy
por: Duong, Tina, et al.
Publicado: (2021)

Advances and limitations for the treatment of spinal muscular atrophy
por: Day, John W., et al.
Publicado: (2022)

Investigation on the Effects of Modifying Genes on the Spinal Muscular Atrophy Phenotype
por: Zhuri, Drenushe, et al.
Publicado: (2022)

Therapeutic decisions under uncertainty for spinal muscular atrophy: The DECISIONS-SMA study protocol
por: Saposnik, Gustavo, et al.
Publicado: (2022)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Parents' dilemma: A therapeutic decision for children with spinal muscular atrophy (SMA) type 1
por: Boursange, Sophie, et al.
Publicado: (2022)

Base editing as a genetic treatment for spinal muscular atrophy
por: Alves, Christiano R. R., et al.
Publicado: (2023)

Survival analysis of spinal muscular atrophy type I
por: Park, Hyun Bin, et al.
Publicado: (2010)

Developmental milestones in type I spinal muscular atrophy
por: De Sanctis, Roberto, et al.
Publicado: (2016)

Choosing Life with Spinal Muscular Atrophy Type 1
por: Lavie, Moran, et al.
Publicado: (2020)

A Patient-Centered Evaluation of Meaningful Change on the 32-Item Motor Function Measure in Spinal Muscular Atrophy Using Qualitative and Quantitative Data
por: Duong, Tina, et al.
Publicado: (2022)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
por: Hensel, Niko, et al.
Publicado: (2020)

Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
por: Tanaka, Fumiaki, et al.
Publicado: (2012)

Current and emerging treatment options for spinal muscular atrophy
por: Farooq, Faraz, et al.
Publicado: (2015)

Experiences of Health Care and Psychosocial Needs in Parents of Children with Spinal Muscular Atrophy
por: Inhestern, Laura, et al.
Publicado: (2023)

Longitudinal characterization of biomarkers for spinal muscular atrophy
por: Bonati, Ulrike, et al.
Publicado: (2017)

Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
por: Dangouloff, Tamara, et al.
Publicado: (2019)

Timing is everything: Clinical evidence supports pre-symptomatic treatment for spinal muscular atrophy
por: Motyl, Anna A.L., et al.
Publicado: (2022)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u7kt5u4b4r1s6387geel6qmheq